Search
for
Sort by
Research 30 of 515
- Finasteride use and suicide attempts through self-poisoning: A case–control study
- Hair stress hormones in individuals with a recent suicide attempt experiencing a depressive episode
- Suicidal behaviors (suicidal ideation, suicide attempt and completed suicide) in patients treated with finasteride for hair loss: Results from the U.S. FDA Adverse Event Reporting System (FAERS) database
- Cerebral Ischemia Related to Isotretinoin; Venlafaxine-Induced Alopecia; Cognitive Dysfunction with Tolterodine; Retinal Artery Occlusion after Injection of Long-Acting Risperidone; Olanzapine-Induced Chylomicronemia Presenting as Pancreatitis; Metabolic Effects of the Atypical Antipsychotics – an Editorial; Another Drug-Induced Pancreatitis – This One Caused by a Tyrosine Kinase Inhibitor; Suicide Attempts Related to Antidepressant Medications
- 76976 Association of Depression with Finasteride Stratified by Dosage and Diagnosis: A Retrospective Cohort Study Using the TriNetX Database
- Sun behaviors and quality of life after first cutaneous melanoma diagnosis
- Sun protection policies and behaviors among U.S. child care centers
- Sunscreen: Cosmetic or medical therapy?
- En pacientes jóvenes, el uso de finasteride podría asociarse con mayor riesgo de ansiedad, depresión y eventos adversos relacionados con el suicidio
- Sub-acute Toxicosis Caused by a Multiple Doses Tegafur/Uracil (UFT) for Suicide: A Case Report
- Divalproex-Induced Alopecia: A Case Report
- Clinical Management of Youth with Gender Dysphoria in Vancouver
- Transgender Competent Provider
- Alopecia areata incognita
- The Muscle Immobility of Depression—The Weightlessness Within
- A Study on the Muscle Immobility of Depression: the Weightlessness within
- PO-0172 Behind Closed Doors: The Effects Of Childhood Cancer On Somatic Health Of Parents During And After Oncologic Therapy
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
- Age-induced hair greying - the multiple effects of oxidative stress
- Finasteride Use: Evaluation of Depression and Suicide Risk
- Finasteride Use Does Not Lead to Depression or Suicide: Insights From a Large‐Scale Cohort Study and Mendelian Randomization Analysis
- Finasteride, pharmacogenomics, and suicide risk: a public health concern
- Isolated depressive disorders and suicidality with finasteride use for androgenetic alopecia: a call for enhanced vigilance
- Association of Suicidality and Depression With 5α-Reductase Inhibitors
- Submission to the College of Physicians and Surgeons of Ontario Re: Medical Assistance in Dying
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- Differential association between cumulative dose of 5α-reductase inhibitors and mortality
- Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications